AIHLF
Price
$3.50
Change
+$1.05 (+42.86%)
Updated
Jul 23 closing price
Capitalization
639.1M
Intraday BUY SELL Signals
ALVO
Price
$5.10
Change
-$0.11 (-2.11%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
1.63B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AIHLF vs ALVO

Header iconAIHLF vs ALVO Comparison
Open Charts AIHLF vs ALVOBanner chart's image
Adcock Ingram Holdings
Price$3.50
Change+$1.05 (+42.86%)
Volume$100
Capitalization639.1M
Alvotech
Price$5.10
Change-$0.11 (-2.11%)
Volume$3.53K
Capitalization1.63B
AIHLF vs ALVO Comparison Chart in %
ALVO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AIHLF vs. ALVO commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIHLF is a StrongBuy and ALVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (AIHLF: $3.50 vs. ALVO: $5.21)
Brand notoriety: AIHLF and ALVO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AIHLF: 100% vs. ALVO: 62%
Market capitalization -- AIHLF: $639.1M vs. ALVO: $1.63B
AIHLF [@Pharmaceuticals: Generic] is valued at $639.1M. ALVO’s [@Pharmaceuticals: Generic] market capitalization is $1.63B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.79B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIHLF’s FA Score shows that 1 FA rating(s) are green whileALVO’s FA Score has 0 green FA rating(s).

  • AIHLF’s FA Score: 1 green, 4 red.
  • ALVO’s FA Score: 0 green, 5 red.
According to our system of comparison, AIHLF is a better buy in the long-term than ALVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 6 TA indicator(s) are bullish.

  • ALVO’s TA Score: 6 bullish, 3 bearish.

Price Growth

AIHLF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while ALVO (@Pharmaceuticals: Generic) price change was -1.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.90%. For the same industry, the average monthly price growth was -2.44%, and the average quarterly price growth was +12.84%.

Reported Earning Dates

ALVO is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.90% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($1.63B) has a higher market cap than AIHLF($639M). ALVO has higher P/E ratio than AIHLF: ALVO (22.70) vs AIHLF (10.66). ALVO YTD gains are higher at: 1.559 vs. AIHLF (0.000). AIHLF has higher annual earnings (EBITDA): 1.47B vs. ALVO (113M). AIHLF has more cash in the bank: 104M vs. ALVO (42.8M). AIHLF has less debt than ALVO: AIHLF (244M) vs ALVO (1.28B). AIHLF has higher revenues than ALVO: AIHLF (9.76B) vs ALVO (571M).
AIHLFALVOAIHLF / ALVO
Capitalization639M1.63B39%
EBITDA1.47B113M1,304%
Gain YTD0.0001.559-
P/E Ratio10.6622.7047%
Revenue9.76B571M1,709%
Total Cash104M42.8M243%
Total Debt244M1.28B19%
TECHNICAL ANALYSIS
Technical Analysis
AIHLFALVO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
47%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
4%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
4%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
64%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ALVO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PREQX6.360.04
+0.63%
PACE Global Real Estate Securities P
DRRIX17.430.10
+0.58%
BNY Mellon Global Real Return - I
ABSIX21.280.05
+0.24%
AB Discovery Value I
JFDRX13.75-0.05
-0.36%
JHancock Financial Industries R6
JMGFX50.81-0.51
-0.99%
JPMorgan Mid Cap Growth R5

AIHLF and

Correlation & Price change

A.I.dvisor tells us that AIHLF and BFRI have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AIHLF and BFRI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIHLF
1D Price
Change %
AIHLF100%
N/A
BFRI - AIHLF
22%
Poorly correlated
-4.13%
TKNO - AIHLF
20%
Poorly correlated
+2.95%
ALVO - AIHLF
8%
Poorly correlated
-2.07%
CTOR - AIHLF
7%
Poorly correlated
+2.78%
IXHL - AIHLF
6%
Poorly correlated
-4.87%
More

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and PAHC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and PAHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-2.07%
PAHC - ALVO
26%
Poorly correlated
-1.43%
EBS - ALVO
24%
Poorly correlated
-1.45%
CRON - ALVO
23%
Poorly correlated
+2.39%
VTRS - ALVO
22%
Poorly correlated
N/A
ACB - ALVO
22%
Poorly correlated
+3.57%
More